Endeavor

Moffitt Launches Immunotherapy Podcast

Monthly series highlights visionaries in immunotherapy and the breakthroughs that are transforming lives

Moffitt Study Shows New Immune Boost Could Expand Access to Cancer Immunotherapy

Adding a natural protein improves the speed and success of TIL manufacturing, potentially benefiting more patients

Imaging Innovations Could Lead to Better Kidney Cancer Treatment

New technology is helping researchers understand how kidney cancer evades the immune system

Immunotherapy May Help Prevent Acute Myeloid Leukemia Relapse After Transplant

Early phase 1 trial results indicate safety and efficacy of donor gamma delta T cell infusions

Access to Treatment is Hurdle to be Conquered for Multiple Myeloma Patients

CAR T treatments have revolutionized care, but some communities struggle to receive it

Top Moffitt Research Stories of 2024

From FDA approvals to drug discovery, Moffitt led the way this past year

Personalized Vaccine Shows Promise in Early HER2-Positive Breast Cancer

Dendritic cell vaccine uses immune cells collected from the patient, which are enhanced in the lab and injected directly into the primary breast tumor

Drug Aims To Improve Transplant Success for Myelofibrosis Patients

Study shows giving patients fedratinib is safe and could help reduce chance of relapse

Moffitt Study Explores Key Risk Factors To Better Personalize CAR T-Cell Therapy

The study analyzed ide-cel to help physicians intervene and reduce toxicities in multiple myeloma patients